NextCure, Inc.
NXTC
$5.22
$0.0851.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.50% | -19.12% | -20.24% | -22.06% | -21.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.31% | -19.99% | -15.42% | -13.04% | -13.07% |
| Operating Income | -0.31% | 19.99% | 15.42% | 13.04% | 13.07% |
| Income Before Tax | 0.57% | 22.30% | 11.27% | 10.74% | 12.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.57% | 22.30% | 11.27% | 10.74% | 12.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.57% | 22.30% | 11.27% | 10.74% | 12.67% |
| EBIT | -0.31% | 19.99% | 15.42% | 13.04% | 13.07% |
| EBITDA | -1.32% | 19.86% | 15.03% | 12.51% | 12.83% |
| EPS Basic | 1.66% | 22.63% | 11.67% | 11.16% | 13.06% |
| Normalized Basic EPS | -2.59% | 19.42% | 15.71% | 15.02% | 16.67% |
| EPS Diluted | 1.66% | 22.63% | 11.67% | 11.16% | 13.06% |
| Normalized Diluted EPS | -2.59% | 19.42% | 15.71% | 15.02% | 16.67% |
| Average Basic Shares Outstanding | 0.78% | 0.44% | 0.46% | 0.48% | 0.44% |
| Average Diluted Shares Outstanding | 0.78% | 0.44% | 0.46% | 0.48% | 0.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |